shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name
RAL-MED-2de63afb-1,Z4497196437,C16H15N3O3,Racemic or presumed racemic or meso,297.308,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_A,O=C(CC=1C=CC=NC1)NC=2C=CC=C(OC3CC(=O)N3)C2,N-{3-[(4-oxoazetidin-2-yl)oxy]phenyl}-2-(pyridin-3-yl)acetamide
JAN-GHE-83b26c96-24,Z1663987506,C14H10ClN3O,Achiral,271.701,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_B,CC=1C=CN=CC1C2=NN=C(O2)C=3C=CC=C(Cl)C3,"3-[5-(3-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-methylpyridine"
TRY-UNI-2eddb1ff-1,Z4497196465,C14H12N4O,Achiral,252.271,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_C,CC=1C=CN=CC1NC(=O)CC=2C=NC=C(C#N)C2,2-(5-cyanopyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide
Z1347557460,Z1347557460,C18H24N2O3,Racemic or presumed racemic or meso,316.394,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_D,CC=1C=C(C=CC1OCC(O)CN2C=NC=CC2=O)C(C)(C)C,"3-[3-(4-tert-butyl-2-methylphenoxy)-2-hydroxypropyl]-3,4-dihydropyrimidin-4-one"
Z4498832235,Z4498832235,C24H38N4O3,Racemic or presumed racemic or meso,430.583,95.49,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_E,CCN1CCN(CC=2C=CC=CC2CNC(=O)C3(C)CCN3C(=O)OC(C)(C)C)CC1,tert-butyl 2-[({2-[(4-ethylpiperazin-1-yl)methyl]phenyl}methyl)carbamoyl]-2-methylazetidine-1-carboxylate
JAN-GHE-83b26c96-6,Z3615034901,C16H18ClN3O,Racemic or presumed racemic or meso,303.786,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_F,CC(C)C=1N=CN=CC1NC(=O)C(C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-N-[4-(propan-2-yl)pyrimidin-5-yl]propanamide
JAN-GHE-83b26c96-3,Z1264534125,C17H15ClN4O,Racemic or presumed racemic or meso,326.78,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_G,CC(C(=O)NC=1C=NC=CC1N2C=CC=N2)C=3C=CC=C(Cl)C3,2-(3-chlorophenyl)-N-[4-(1H-pyrazol-1-yl)pyridin-3-yl]propanamide
RAL-MED-2de63afb-12,Z4497196435,C15H16N4O2,Achiral,284.313,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_H,CC(=O)NCC=1C=CC=C(NC(=O)CC=2C=NC=NC2)C1,N-({3-[2-(pyrimidin-5-yl)acetamido]phenyl}methyl)acetamide
TRY-UNI-2eddb1ff-7,Z4497196461,C17H16ClN3O3,Racemic or presumed racemic or meso,345.78,97.47,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_I,CC=1C=CN=CC1NC(=O)CC=2C=C(Cl)C=C(OC3CC(=O)N3)C2,2-{3-chloro-5-[(4-oxoazetidin-2-yl)oxy]phenyl}-N-(4-methylpyridin-3-yl)acetamide
JAR-KUA-672-1,Z2782173902,C16H20N2O3S2,Racemic or presumed racemic or meso,352.471,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_J,O=C(N1CCOC(CN2CCOCC2)C1)C3=CC=4SC=CC4S3,"2-[(morpholin-4-yl)methyl]-4-{thieno[3,2-b]thiophene-2-carbonyl}morpholine"
RAL-MED-2de63afb-2,Z4497196429,C16H16N4O3,Racemic or presumed racemic or meso,312.323,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_K,CC=1C=C(NC(=O)CC=2C=NC=NC2)C=C(OC3CC(=O)N3)C1,N-{3-methyl-5-[(4-oxoazetidin-2-yl)oxy]phenyl}-2-(pyrimidin-5-yl)acetamide
Z4498832237,Z4498832237,C18H22BrN3O2,Achiral,392.29,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_L,CC=1C=CC(NCC=2C=C(NC(=O)OC(C)(C)C)C=CC2Br)=CN1,tert-butyl N-(4-bromo-3-{[(6-methylpyridin-3-yl)amino]methyl}phenyl)carbamate
JAG-UCB-a3ef7265-20,Z2077725504,C15H15ClN4O2,Racemic or presumed racemic or meso,318.758,96.04,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_M,ClC=1C=CC=2OCCC(C(=O)NC3=NN=CN3C4CC4)C2C1,"6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
JAG-UCB-a3ef7265-24,Z1715965908,C18H17N5O2,Racemic or presumed racemic or meso,335.359,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_N,CC=1C=C2OCC(C(=O)NC=3C=NC=NC3N4C=CC=N4)C2=CC1C,"5,6-dimethyl-N-[4-(1H-pyrazol-1-yl)pyrimidin-5-yl]-2,3-dihydro-1-benzofuran-3-carboxamide"
JAG-UCB-a3ef7265-21,Z416902834,C13H13F3N2O3S,Racemic or presumed racemic or meso,334.314,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_O,CC(C1=NC(C)=NO1)S(=O)(=O)CC=2C=CC=C(C2)C(F)(F)F,"3-methyl-5-(1-{[3-(trifluoromethyl)phenyl]methanesulfonyl}ethyl)-1,2,4-oxadiazole"
JAN-GHE-83b26c96-9,Z1344037982,C17H19ClN2O,Racemic or presumed racemic or meso,302.798,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,03_P,CC(C)C(C(=O)NC=1C=NC=CC1C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-3-methyl-N-(4-methylpyridin-3-yl)butanamide
RAL-MED-2de63afb-14,Z4497196433,C15H13FN4O3,Racemic or presumed racemic or meso,316.287,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_A,FC=1C=C(NC(=O)CC=2C=NC=NC2)C=C(OC3CC(=O)N3)C1,N-{3-fluoro-5-[(4-oxoazetidin-2-yl)oxy]phenyl}-2-(pyrimidin-5-yl)acetamide
JAN-GHE-83b26c96-1,Z3083887489,C15H16ClN3O,Racemic or presumed racemic or meso,289.76,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_B,CCC(C(=O)NC=1C=NN=CC1C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-N-(5-methylpyridazin-4-yl)butanamide
JAN-GHE-83b26c96-2,Z1739759863,C16H16ClN3O2,Racemic or presumed racemic or meso,317.77,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_C,CC(C(=O)NC=1C=NC=CC1NC(=O)C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-N-(4-acetamidopyridin-3-yl)propanamide
RAL-MED-2de63afb-3,Z2174393016,C16H16N4O2,Racemic or presumed racemic or meso,296.323,90.72,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_D,O=C(CC=1C=NC=NC1)NC=2C=CC=C(C2)C3CNC(=O)C3,N-[3-(5-oxopyrrolidin-3-yl)phenyl]-2-(pyrimidin-5-yl)acetamide
Z4498832236,Z4498832236,C26H35N3O3,Single known enantiomer,437.574,98,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_E,CCOC(=O)[C@H](CCC=1C=CC=CC1)N[C@@H](C)C(=O)NC=2C=CC=C(CN3CCCC3)C2,ethyl (2S)-4-phenyl-2-{[(1S)-1-({3-[(pyrrolidin-1-yl)methyl]phenyl}carbamoyl)ethyl]amino}butanoate
JAN-GHE-83b26c96-20,Z1129286981,C16H15ClN2O,Achiral,286.756,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_F,CC=1C=CN=CC1NC(=O)C2(CC2)C=3C=CC=C(Cl)C3,1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)cyclopropane-1-carboxamide
EDJ-MED-49816e9b-2,Z2194192724,C15H15ClN2O,Achiral,274.745,98.3,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_G,CC=1C=CN=C(C)C1NC(=O)CC=2C=CC=C(Cl)C2,"2-(3-chlorophenyl)-N-(2,4-dimethylpyridin-3-yl)acetamide"
DAR-DIA-842-18,Z4452238001,C14H13N3OS,Achiral,271.337,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_H,CC1=CC=C(NC(=O)CC2=CC3=CC=CNC3=N2)S1,"N-(5-methylthiophen-2-yl)-2-{7H-pyrrolo[2,3-b]pyridin-2-yl}acetamide"
JAN-GHE-83b26c96-10,Z1256294224,C16H18ClN3O,Racemic or presumed racemic or meso,303.786,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_I,CN(C)C(C(=O)NC=1C=NC=CC1C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-2-(dimethylamino)-N-(4-methylpyridin-3-yl)acetamide
JAN-GHE-83b26c96-23,Z1129288941,C14H11ClF2N2O,Achiral,296.699,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_J,CC=1C=CN=CC1NC(=O)C(F)(F)C=2C=CC=C(Cl)C2,"2-(3-chlorophenyl)-2,2-difluoro-N-(4-methylpyridin-3-yl)acetamide"
JAG-UCB-a3ef7265-3,Z1852878836,C15H13ClN2O3,Racemic or presumed racemic or meso,304.728,98.32,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_K,OCC=1C=CN=CC1NC(=O)C2COC=3C=CC(Cl)=CC23,"5-chloro-N-[4-(hydroxymethyl)pyridin-3-yl]-2,3-dihydro-1-benzofuran-3-carboxamide"
GIA-UNK-20b-6,Z4505379463,C19H28Cl2N2O,Racemic or presumed racemic or meso,371.344,96.23,200415-FTE / COVID-19,hydrogen chloride,1,36.46094,40,20,1178796-Y40-06,04_L,Cl.ClCC(=O)N1CCN(CC1)C(C2CCCCC2)C=3C=CC=CC3,2-chloro-1-{4-[cyclohexyl(phenyl)methyl]piperazin-1-yl}ethan-1-one hydrochloride
JAN-GHE-bf4-2,Z4461624259,C25H23N5O3S,Achiral,473.546,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_M,C=CC(=O)N1CCN(CC1)S(=O)(=O)C=2C=CC=CC2C=3C=CC(NC=4C=CC(C#N)=CN4)=CC3,"6-[(2'-{[4-(prop-2-enoyl)piperazin-1-yl]sulfonyl}-[1,1'-biphenyl]-4-yl)amino]pyridine-3-carbonitrile"
Z3496329867,Z3496329867,C12H12ClN3O3S,Racemic or presumed racemic or meso,313.759,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_N,OC(=O)C(CC=1N=CC=C(O)N1)NCC2=CC=C(Cl)S2,2-{[(5-chlorothiophen-2-yl)methyl]amino}-3-(4-hydroxypyrimidin-2-yl)propanoic acid
Z2809506569,Z2809506569,C19H26N2O5,Racemic diastereomer with known relative stereochemistry,362.42,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_O,"OCCOC=1C=CC=CC1CNC(=O)C(=O)N[C@@H]2C[C@H]2C3CCOCC3 |&1:17,19,r|","rac-N'-{[2-(2-hydroxyethoxy)phenyl]methyl}-N-[(1R,2S)-2-(oxan-4-yl)cyclopropyl]ethanediamide"
BEN-DND-7e92b6ca-5,Z4503232150,C18H16N2O3,Achiral,308.331,95.88,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,04_P,O=C(NCCOC=1C=CC=CC1)C2=CC(=O)NC=3C=CC=CC23,"2-oxo-N-(2-phenoxyethyl)-1,2-dihydroquinoline-4-carboxamide"
BEN-DND-7e92b6ca-4,Z4503232207,C18H17N3O2,Achiral,307.346,97.15,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_A,O=C(NCCNC=1C=CC=CC1)C2=CC(=O)NC=3C=CC=CC23,"2-oxo-N-[2-(phenylamino)ethyl]-1,2-dihydroquinoline-4-carboxamide"
BEN-DND-7e92b6ca-7,Z4503232265,C20H19N3O4S,Achiral,397.447,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_B,O=C(N1CCN(CC1)S(=O)(=O)C=2C=CC=CC2)C3=CC(=O)NC=4C=CC=CC34,"4-[4-(benzenesulfonyl)piperazine-1-carbonyl]-1,2-dihydroquinolin-2-one"
BEN-DND-7e92b6ca-3,Z4503232477,C19H19N3O2,Achiral,321.373,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_C,CN(CCNC(=O)C1=CC(=O)NC=2C=CC=CC12)C=3C=CC=CC3,"N-{2-[methyl(phenyl)amino]ethyl}-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-60,Z1245884481,C21H17FN4O4S,Achiral,440.447,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_D,FC=1C=CC=2C(=CC(=O)NC2C1)C(=O)N3CCN(CC3)S(=O)(=O)C=4C=CC(C#N)=CC4,"4-{[4-(7-fluoro-2-oxo-1,2-dihydroquinoline-4-carbonyl)piperazin-1-yl]sulfonyl}benzonitrile"
MAT-POS-590ac91e-61,Z1245866299,C21H17FN4O4S,Achiral,440.447,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_E,FC=1C=CC=2C(=CC(=O)NC2C1)C(=O)N3CCN(CC3)S(=O)(=O)C=4C=CC=CC4C#N,"2-{[4-(7-fluoro-2-oxo-1,2-dihydroquinoline-4-carbonyl)piperazin-1-yl]sulfonyl}benzonitrile"
MAT-POS-590ac91e-37,Z1245987199,C20H19FN2O4,Achiral,370.374,99.49,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_F,COC=1C=CC=CC1OCCN(C)C(=O)C2=CC(=O)NC=3C=C(F)C=CC23,"7-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-38,Z1275021767,C20H19FN2O4,Racemic or presumed racemic or meso,370.374,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_G,COC=1C=CC=CC1OC(C)CNC(=O)C2=CC(=O)NC=3C=C(F)C=CC23,"7-fluoro-N-[2-(2-methoxyphenoxy)propyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-63,Z1245857146,C22H22FN3O4S,Achiral,443.491,98.7,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_H,CC=1C=CC(=C(C)C1)S(=O)(=O)N2CCN(CC2)C(=O)C3=CC(=O)NC=4C=C(F)C=CC34,"4-[4-(2,4-dimethylbenzenesulfonyl)piperazine-1-carbonyl]-7-fluoro-1,2-dihydroquinolin-2-one"
MAT-POS-590ac91e-57,Z1245857491,C20H18FN3O4S,Achiral,415.438,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_I,FC=1C=CC=2C(=CC(=O)NC2C1)C(=O)N3CCN(CC3)S(=O)(=O)C=4C=CC=CC4,"4-[4-(benzenesulfonyl)piperazine-1-carbonyl]-7-fluoro-1,2-dihydroquinolin-2-one"
MAT-POS-590ac91e-46,Z1245945428,C22H21FN2O4,Achiral,396.411,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_J,CC1(C)CC=2C=CC=C(OCCNC(=O)C3=CC(=O)NC=4C=C(F)C=CC34)C2O1,"N-{2-[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]ethyl}-7-fluoro-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-40,Z1245992131,C20H19FN2O4,Racemic or presumed racemic or meso,370.374,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_K,COC=1C=CC=CC1OCC(C)NC(=O)C2=CC(=O)NC=3C=C(F)C=CC23,"7-fluoro-N-[1-(2-methoxyphenoxy)propan-2-yl]-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-32,Z1245862555,C19H17FN2O4,Achiral,356.347,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_L,COC=1C=CC=CC1OCCNC(=O)C2=CC(=O)NC=3C=C(F)C=CC23,"7-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide"
MAT-POS-590ac91e-65,Z1245858064,C21H20FN3O5S,Achiral,445.464,97.32,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_M,COC=1C=CC(=CC1)S(=O)(=O)N2CCN(CC2)C(=O)C3=CC(=O)NC=4C=C(F)C=CC34,"7-fluoro-4-[4-(4-methoxybenzenesulfonyl)piperazine-1-carbonyl]-1,2-dihydroquinolin-2-one"
MAT-POS-590ac91e-31,Z1245860584,C19H15FN2O4,Racemic or presumed racemic or meso,354.331,96.96,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_N,FC=1C=CC=2C(=CC(=O)NC2C1)C(=O)NCC3COC=4C=CC=CC4O3,"N-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-7-fluoro-2-oxo-1,2-dihydroquinoline-4-carboxamide"
ALP-POS-95b75b4d-1,Z1129284099,C14H13FN2O,Achiral,244.264,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_O,CC=1C=CN=CC1NC(=O)CC=2C=CC=C(F)C2,2-(3-fluorophenyl)-N-(4-methylpyridin-3-yl)acetamide
ALP-POS-95b75b4d-2,Z1124505274,C14H14N2O2,Achiral,242.273,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,05_P,CC=1C=CN=CC1NC(=O)CC=2C=CC=C(O)C2,2-(3-hydroxyphenyl)-N-(4-methylpyridin-3-yl)acetamide
BEN-DND-7e92b6ca-2,Z4503232507,C20H20N2O4,Achiral,352.383,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_A,COC=1C=CC=CC1OCCN(C)C(=O)C2=CC(=O)NC=3C=CC=CC23,"N-[2-(2-methoxyphenoxy)ethyl]-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide"
GIA-UNK-20b-2,Z4505377052,C18H26Cl2N2O2,Racemic or presumed racemic or meso,373.317,100,200415-FTE / COVID-19,hydrogen chloride,1,36.46094,40,20,1178796-Y40-06,06_B,Cl.ClCC(=O)N1CCN(CC1)C(C2CCOCC2)C=3C=CC=CC3,2-chloro-1-{4-[(oxan-4-yl)(phenyl)methyl]piperazin-1-yl}ethan-1-one hydrochloride
ADA-UNI-f8e-5,Z4444622031,C16H19N3O,Racemic or presumed racemic or meso,269.341,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_C,CNCCC(C(=O)NC=1C=CC=NC1)C=2C=CC=CC2,4-(methylamino)-2-phenyl-N-(pyridin-3-yl)butanamide
JAN-GHE-83b26c96-22,Z1233377555,C16H17ClN2O,Achiral,288.771,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_D,CC=1C=CN=CC1NC(=O)C(C)(C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-2-methyl-N-(4-methylpyridin-3-yl)propanamide
JAN-GHE-83b26c96-8,Z2703873624,C17H19ClN2O,Racemic or presumed racemic or meso,302.798,97.29,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_E,CCCC(C(=O)NC=1C=NC=CC1C)C=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)pentanamide
EDJ-MED-e58735b6-2,Z4497196443,C15H16N2O2,Achiral,256.299,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_F,CC=1C=CN=CC1NC(=O)CC=2C=CC=C(CO)C2,2-[3-(hydroxymethyl)phenyl]-N-(4-methylpyridin-3-yl)acetamide
JOH-UNI-27a-32_thio_pH,Z4461624305,C15H18Cl2N2O,Achiral,313.222,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_G,ClCC(=O)N1CCN(CC1)C2(CC2)C=3C=CC=C(Cl)C3,2-chloro-1-{4-[1-(3-chlorophenyl)cyclopropyl]piperazin-1-yl}ethan-1-one
RAL-MED-2de63afb-10,Z4497196436,C13H14N2O3,Racemic or presumed racemic or meso,246.261,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_H,C/C=C/C(=O)NC=1C=CC=C(OC2CC(=O)N2)C1,(2E)-N-{3-[(4-oxoazetidin-2-yl)oxy]phenyl}but-2-enamide
Z4459610245,Z4459610245,C22H26IN3O2,Racemic or presumed racemic or meso,491.365,82.35,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_I,CCC=1C=CC(=CC1I)N(C(C(=O)NC(C)(C)C)C=2C=CC=NC2)C(=O)C=C,N-[(tert-butylcarbamoyl)(pyridin-3-yl)methyl]-N-(4-ethyl-3-iodophenyl)prop-2-enamide
Z4459610279,Z4459610279,C22H31N3O2,Diastereomeric mixture,369.5,98,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_J,CC(C)(C)NC(=O)C(N(C1CC21CC(C)(C)C2)C(=O)C=C)C=3C=CC=NC3,"N-[(tert-butylcarbamoyl)(pyridin-3-yl)methyl]-N-{5,5-dimethylspiro[2.3]hexan-1-yl}prop-2-enamide"
Z4457849203,Z4457849203,C27H28FN3O2,Racemic or presumed racemic or meso,445.528,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-06,06_K,CC=1C=C(F)C=CC1NC(=O)C(N(C(=O)C=C)C=2C=CC(=CC2)C(C)(C)C)C=3C=CC=NC3,N-(4-tert-butylphenyl)-N-{[(4-fluoro-2-methylphenyl)carbamoyl](pyridin-3-yl)methyl}prop-2-enamide